Recombinant GLP-1-Fc fusion protein (China Resources Angde)

重组胰高血糖素样肽-1-Fc融合蛋白（华润昂德）

Report date: 2022/04/01 18:05:42

Base Information

Drug NameRecombinant GLP-1-Fc fusion protein (China Resources Angde)
Drug Alias NameDulaglutide Biosimilar (China Resources Angde)度拉糖肽生物类似药（华润昂德）重组胰高血糖素样肽-1-Fc融合蛋白注射液（华润昂德）
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesChina Resources Angde Biotech Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChina Resources Angde Biotech Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A